Grant: Collaborative Research and Development Grants
University of British Columbia
$153,000.00
Development of handheld microfluidic breath-analyzer to detect tetrahydrocannabinol and other target volatile organic compounds
FY 2019-20
Summary
Perspectives on cannabis have shifted in recent decades due to increased understanding of its medicinal qualities and mounting public support for legalization of recreational use. Typically, cannabis use is separated into two categories, with medicinal users seeking to reduce symptoms of their ailment and recreational users desiring euphoric effects. Consequently, the amount of psychoactive chemicals (e.g., tetrahydrocannabinol (THC)) in the blood stream can depend on the type of user, which is an important distinction when testing for impairment. Current technology focuses on blood and saliva samples, which are unfavourable due to either invasive sample collection or poor accuracy. Breath analysis is a promising alternative as it is both non-invasive and, since the concentration of THC in breath closely matches the levels present in blood, it provides accurate results. However, breath analysis has many challenges, including controlling for humidity and discriminating between chemicals in exhaled breath. Our technology pairs a metal-oxide semiconductor with a microfluidic channel of specific geometry and coatings; this provides a highly sensitive and selective method of detection that is much more portable than conventional methods, such as gas chromatography. We will develop a solution for monitoring THC in breath in the following objectives: (1) improve response time of existing gas sensor technology, (2) control for signal interference (e.g., humidity), (3) develop cartridges for sample collection, (4) use machine learning to calibrate device to human breath, (5) package sensor within a ruggedized portable setup, and (6) validate prototype and correlate breath samples to plasma concentration of THC in collaboration with industry partners. Ultimately, this technology will not only provide a non-invasive tool that allows cannabis users to be more aware about their level of exposure but can also be packaged to serve as a screening tool to help enforce designated exposure limits in workplaces and by law enforcement. This translates into individuals having a better understanding of their cannabis intake, safer roads and work environments, as well as having a new tool to study the complexity of THC-induced impairment.
Program
Collaborative Research and Development Grants
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
522791-2017
Name nom
Hoorfar, Mina
Department département
Okanagan - Engineering, School of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2017
Award amount
153000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2518
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Instrumentation and measurements
Research subject fr
Instrumentation et mesures
Installment
inst:2 - 2
Partie
2
Nb partie
2
Application title
Development of handheld microfluidic breath-analyzer to detect tetrahydrocannabinol and other target volatile organic compounds
Keyword
NSERC
Application summary
Perspectives on cannabis have shifted in recent decades due to increased understanding of its medicinal qualities and mounting public support for legalization of recreational use. Typically, cannabis use is separated into two categories, with medicinal users seeking to reduce symptoms of their ailment and recreational users desiring euphoric effects. Consequently, the amount of psychoactive chemicals (e.g., tetrahydrocannabinol (THC)) in the blood stream can depend on the type of user, which is an important distinction when testing for impairment. Current technology focuses on blood and saliva samples, which are unfavourable due to either invasive sample collection or poor accuracy. Breath analysis is a promising alternative as it is both non-invasive and, since the concentration of THC in breath closely matches the levels present in blood, it provides accurate results. However, breath analysis has many challenges, including controlling for humidity and discriminating between chemicals in exhaled breath. Our technology pairs a metal-oxide semiconductor with a microfluidic channel of specific geometry and coatings; this provides a highly sensitive and selective method of detection that is much more portable than conventional methods, such as gas chromatography. We will develop a solution for monitoring THC in breath in the following objectives: (1) improve response time of existing gas sensor technology, (2) control for signal interference (e.g., humidity), (3) develop cartridges for sample collection, (4) use machine learning to calibrate device to human breath, (5) package sensor within a ruggedized portable setup, and (6) validate prototype and correlate breath samples to plasma concentration of THC in collaboration with industry partners. Ultimately, this technology will not only provide a non-invasive tool that allows cannabis users to be more aware about their level of exposure but can also be packaged to serve as a screening tool to help enforce designated exposure limits in workplaces and by law enforcement. This translates into individuals having a better understanding of their cannabis intake, safer roads and work environments, as well as having a new tool to study the complexity of THC-induced impairment.